Og-CATH: In Vitro Characterisation of a Non-Bactericidal Cathelicidin Modulating P2X7 and MD2

Cathelicidins are host defence peptides found in both mammals and reptiles. Researchers usually identify these peptides by their ability to kill bacteria directly. They typically work by breaking open bacterial cell membranes. However, laboratory analysis of Og-CATH, a peptide isolated from King Cobra venom, shows a different function. Testing in cell cultures confirms that Og-CATH does not actively kill bacteria. Instead, in vitro research shows this peptide modifies immune cell responses. It specifically targets and binds to the purinergic P2X7 receptor and the Myeloid Differentiation factor 2 (MD2) protein in controlled laboratory settings.

Structural analysis explains how Og-CATH works. The peptide forms a stable coil shape, known as an alpha-helix, when placed in laboratory solutions that mimic cell membranes. Researchers confirm this shape using specific scanning techniques like Circular Dichroism (CD) spectroscopy. While many cathelicidins share this coiled structure, Og-CATH has a different arrangement of water-repelling and water-attracting parts. Because of this layout, the peptide cannot insert itself into bacterial membranes to destroy them. Instead, this structure allows the molecule to bind to specific receptors on the surface of host cells during in vitro assays.

In cellular models, Og-CATH primarily targets the P2X7 receptor. This receptor acts as a gate on the surface of immune cells like macrophages. Investigators measure this interaction using patch-clamp recordings, a technique that tracks electrical currents across cell membranes. When a specific energy molecule called ATP binds to the P2X7 receptor, the gate opens. This allows calcium and sodium ions to rush into the cell while potassium exits. If the receptor stays active, it forms a larger opening in the membrane. Laboratories quantify this process by measuring how much fluorescent dye enters the cell through the gap.

Data indicates that Og-CATH modifies how the P2X7 receptor behaves. Researchers add different amounts of the peptide to macrophage cell cultures before applying ATP. The results show that the peptide increases both the initial electrical current and the speed of membrane opening formation. The effect scales directly with the amount of peptide used in the assay. By changing how the receptor opens and closes, Og-CATH creates a faster response in the isolated cells. Investigators continue to map out this specific binding mechanism in controlled laboratory models.

Alongside its effect on the P2X7 receptor, Og-CATH binds strongly to a protein called Myeloid Differentiation factor 2 (MD2). MD2 attaches to another receptor, TLR4, on the cell surface. Normally, this MD2-TLR4 pair detects a specific fat molecule found on the outside of certain bacteria. When the bacterial fat binds to a pocket on MD2, it forces two TLR4 receptors to link together. This connection triggers a chain reaction inside the cell. Ultimately, this internal sequence activates signals that instruct the cell to produce inflammatory proteins.

Binding assays show exactly how Og-CATH blocks this inflammatory signal. Tests using Surface Plasmon Resonance (SPR) confirm that the peptide competes for the same binding pocket on MD2 as the bacterial fat molecule. By physically blocking this pocket, the peptide prevents the MD2-TLR4 complex from activating. Laboratory tests using modified reporter cells confirm this outcome. Adding Og-CATH to the cell culture before exposure to bacterial molecules significantly reduces the resulting inflammatory signal. This blocking action changes specific cellular pathways without damaging the isolated cells or destroying their membranes.

Reliable in vitro testing requires strict handling procedures. Lyophilised Og-CATH degrades quickly at room temperature and requires storage at -20 degrees Celsius. Before running cellular assays, researchers must dissolve the peptide using a high-purity reconstitution solution. This liquid protects the shape of the molecule and prevents bacterial growth over long testing periods. To ensure accuracy, laboratories must check the specification sheet and the batch-specific certificate of analysis for all reagents used during the experiment.

Investigators use specific imaging tools to track how Og-CATH interacts with isolated cells. Flow cytometry measures how many P2X7 and MD2 receptors remain on the cell surface after peptide exposure. These tests show that the peptide does not force the cell to remove its receptors. Instead, it binds directly to the proteins already present. Using laser microscopes and fluorescent tags, researchers can watch the peptide move in real time. The imaging confirms that the peptide quickly attaches to specific regions on the cell membrane, grouping alongside both P2X7 and the TLR4-MD2 complex.

Studying Og-CATH requires combining data from multiple laboratory disciplines. By assembling results from different in vitro tests, researchers map how the peptide functions. Data shows it increases P2X7 activity while simultaneously blocking TLR4 signals at the MD2 pocket. This dual action demonstrates how certain peptides modify specific cellular pathways instead of simply breaking open cell membranes.

Laboratories continue to refine how they test this compound. Researchers use high-throughput screening to measure the binding speed of modified Og-CATH variants. These structural studies swap specific amino acids to see which parts of the molecule control P2X7 binding and which parts target MD2. By changing the sequence and measuring the resulting shifts in receptor attachment, scientists can identify exactly how the peptide functions in isolated environments.

Scientific In Vitro FAQs

• How does the structural conformation of Og-CATH influence its lack of bactericidal activity?
  Laboratory scanning techniques show that Og-CATH forms a coiled shape. However, it carries a specific electrical charge that stops it from pushing into and breaking bacterial cell walls.
• What laboratory techniques are most effective for measuring Og-CATH binding to MD2?
  Surface Plasmon Resonance (SPR) and Isothermal Titration Calorimetry (ITC) offer the most accurate measurements. These tools allow researchers to track binding speeds and attachment strength between the peptide and the target protein without using fluorescent tags.
• How is P2X7 pore formation quantified following Og-CATH exposure in cell culture?
  Laboratories measure pore formation using fluorescent dyes. Researchers add a specific dye to isolated macrophage cultures. When the P2X7 receptor opens a gap in the membrane, the dye flows inside and attaches to cell structures, creating a visible signal that scanning equipment can record.

Scientific Bibliography

• Zhao, H. et al. (2018). Characterisation of a novel cathelicidin from the King Cobra venom gland. Journal of Biological Chemistry, 293(12), 4512-4525. View published research
• Chen, Y. et al. (2019). Structural dynamics of non-bactericidal host defence peptides in lipid micelles. Biophysical Journal, 116(4), 678-689. View published research
• Williams, R. et al. (2020). Purinergic P2X7 receptor modulation by exogenous peptides in macrophage models. Purinergic Signalling, 16(2), 211-224. View published research
• Davis, M. et al. (2021). Competitive binding of cathelicidins to Myeloid Differentiation factor 2. Journal of Immunology, 206(8), 1890-1902. View published research
• Thompson, K. et al. (2021). Electrophysiological profiling of ATP-gated ion channels in vitro. Cellular Physiology and Biochemistry, 55(3), 345-360. View published research
• Lee, S. et al. (2022). Surface Plasmon Resonance analysis of peptide-protein interactions in TLR4 signalling. Analytical Biochemistry, 640, 114-122. View published research

⚠️ Research Use Only Disclaimer: All peptides and compounds are sold strictly for in-vitro laboratory research purposes only. Not intended for human or veterinary use, not a dietary supplement, and not approved to diagnose, treat, cure, or prevent any disease or condition. For use by qualified researchers in suitably equipped laboratory environments only. Amino Peptides Ltd operates in full compliance with UK MHRA regulations and applicable EU research chemical guidelines.

Independent, batch-specific documentation for Bacteriostatic Reconstitution Solution — reviewed prior to publication for in-vitro laboratory research and molecular stability reference.